Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal versus oral sequential estrogen and progesterone for improving endometrial receptivity
ChiCTR1900026410Phase 4Recruiting
- Sponsor
- Center for Reproductive Medicine
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol and dydrogesterone in ovarian hypofunction (POI) (2 arms), sponsored by Center for Reproductive Medicine. Primary endpoints: estradiol, endometrial thickness and 8 more. Started Oct 2019; status: recruiting.
02
Drugs
estradioldydrogesterone
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on ChiCTR1900026410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026410.